Artiva Biotherapeutics (ARTV) insider trading in the last 6 months
Form 4 filings, newest first
2 insiders bought $109M, 5 sold $2.3M.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Who files at Artiva Biotherapeutics
Cluster buys at ARTV
2 insiders bought ARTV in the last 6 months: RA Capital Management, L.P. and GC Corp..
Questions about ARTV's insider trades
Are ARTV insiders buying or selling?
2 insiders bought $109M across 21 filings, and 5 insiders sold $2.3M across 17 filings, in the last 6 months. The newest filing: Fred Aslan, Chief Executive Officer, sold $260K on Nov 2, 2026. 2 insiders bought ARTV in the last 6 months: RA Capital Management, L.P. and GC Corp..
Who are ARTV's biggest insider sellers?
By the dollars of their sales in the last 6 months: Fred Aslan (Chief Executive Officer), 4 sales; Christopher Horan (Chief Tech Operations Officer), 4 sales; Jennifer Bush (COO, CLO, Compliance Officer), 4 sales. 5 insiders sold in all.
When did an ARTV insider last buy?
RA Capital Management, L.P., 10% owner, bought ARTV shares on Jul 31, 2026, the newest insider buy on record.
Artiva Biotherapeutics's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.